Babic Zorana, Rancic Nemanja, Ilic Sanja, Corovic Snezana, Milicic Vesna, Djordjevic Gordana, Djordjevic Ognjen, Ilic Sladjana, Radevic Svetlana
Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia.
Center for Clinical Pharmacology, Medical Faculty of the Military Medical Academy, University of Defense, Belgrade, Serbia.
Iran J Public Health. 2024 Apr;53(4):828-836. doi: 10.18502/ijph.v53i4.15559.
We aimed to investigating the sex-specific and age-specific melanoma mortality trends observed on the territory of Serbia between 2000 and 2021.
This population-based study used data from the Statistical Office of the Republic of Serbia database during the period 2000-2021. The calculation of the gender and age-standardized rates (ASR) was performed. We used a regression analysis complete with linear trend model.
The mean ASR was 1.77 per 100,000 people, meaning that male mortality rates (2.24 per 100,000) was higher than female mortality rates (1.34 per 100,000). During the observation period, a rising trend in mortality from melanoma skin cancer was reported. Observed by gender, the change of melanoma mortality trend was significant in men (=0.021), but not in women (=0.747). The annual growth rate of ASRs values was 1.43%. A increase in the melanoma mortality rate was observed since 2000 by 2.44% annually in males and by 2.79% annually in females. Mortality rates were increasing in both sexes as they aged, and the greatest number of deaths was recorded in the group of those aged 80 yr or above (16.25 per 100,000 for men; 10.45 per 100,000 for women).
Our study findings underline the importance of launching more effective public health awareness campaigns to educate people about the dangers of melanoma and its symptoms' detection along with establishing a diagnosis at an early stage of the disease, especially among male patients and those at an advanced age.
我们旨在调查2000年至2021年期间塞尔维亚境内观察到的特定性别和特定年龄的黑色素瘤死亡率趋势。
这项基于人群的研究使用了塞尔维亚共和国统计局2000 - 2021年期间数据库中的数据。进行了性别和年龄标准化率(ASR)的计算。我们使用了带有线性趋势模型的回归分析。
平均ASR为每10万人1.77例,这意味着男性死亡率(每10万人2.24例)高于女性死亡率(每10万人1.34例)。在观察期内,报告了皮肤黑色素瘤死亡率呈上升趋势。按性别观察,黑色素瘤死亡率趋势变化在男性中显著(=0.021),但在女性中不显著(=0.747)。ASR值的年增长率为1.43%。自2000年以来,男性黑色素瘤死亡率每年增加2.44%,女性每年增加2.79%。随着年龄增长,两性的死亡率都在上升,80岁及以上年龄组记录的死亡人数最多(男性每10万人16.25例;女性每10万人10.45例)。
我们的研究结果强调了开展更有效的公共卫生宣传活动的重要性,以教育人们了解黑色素瘤的危险及其症状检测,并在疾病早期阶段进行诊断,特别是在男性患者和老年患者中。